SLU-PP-332

SLU-PP-332 | 500mcg Tablets | 100 Count
For In Vitro Research Use Only — Not for Human or Veterinary Use
Description:SLU-PP-332 is a small-molecule compound investigated in vitro as a PPARδ/β agonist with potential applications in metabolic and performance research. Early studies have explored its role in enhancing endurance, promoting lipid metabolism, improving mitochondrial function, and supporting energy expenditure.
This oral tablet format delivers 500mcg per unit, provided in a 100-count bottle for consistent dosing in extended laboratory study protocols.
Specifications:

Dosage Form: Oral tablet (500mcg per tablet)

Bottle Size: 100 tablets

Compound Type: PPARδ/β agonist (investigational)

Molecular Weight: ~exact value varies (small-molecule structure)

Storage: Store sealed in a cool, dry place (2°C–8°C). Protect from heat, light, and humidity.
Application Context:SLU-PP-332 is studied in vitro for its potential roles in:

Mitochondrial biogenesis and energy metabolism

Fatty acid oxidation and endurance-related pathways

Skeletal muscle performance and adaptation

Glucose homeostasis and metabolic health models

Cellular signaling via PPARδ/β receptor activation
Intended Use:This product is intended strictly for in vitro laboratory research use. It is not approved for human or animal administration, and must not be incorporated into foods, supplements, drugs, or cosmetics.
Legal Disclaimer:This product and associated information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding treatment, cure, or prevention of any condition. Research is restricted to qualified professionals in certified laboratory environments.
Terms of Sale:By purchasing from Mile High Compounds, the buyer affirms they are a qualified researcher or institution and assumes full responsibility for proper handling, storage, and legal compliance. All sales are final.